Last reviewed · How we verify

NCT05096429: PROVIDENT

Preventing Overdose Using Information and Data From the Environment

Completed NA Results posted Last updated 9 April 2026
What this trial tests

NA trial testing PROVIDENT in Opioid Overdose in 39 participants. Completed in 15 August 2024.

Timeline
15 November 2021
Primary endpoint
15 August 2024
15 August 2024

Quick facts

Lead sponsorBrown University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposehealth services research
Enrollment39
Start date15 November 2021
Primary completion15 August 2024
Estimated completion15 August 2024
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Brown University

Who can join

Eligibility, any sex, with Opioid Overdose or Drug Overdose. Patients with the condition only — healthy volunteers not accepted.

Results — posted to ClinicalTrials.gov

Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.

Cumulative Incidence of Accidental Fatal and Non-Fatal Drug Overdoses Primary · 0.5 to 2.75 years following intervention, with assessment of primary outcome at 2.75 years

The primary outcome is the cumulative incidence of fatal and non-fatal drug overdoses per 10,000 residents. Fatal overdoses will be defined as drug-related deaths deemed accidental by a state medical examiner. Non-fatal overdoses will be defined as emergency medical services (EMS) runs for suspected non-fatal opioid overdoses identified and classified by the Rhode Island Emergency Medical Services Information System (RI-EMSIS). Since patient outcomes are recorded, patients who did not survive or who were dead upon arrival will be excluded to avoid double-counting.

GroupValue95% CI
Intervention43.5
Control37.1
Number of Participants Engaged in Implementation Activities Secondary · At the time of participation in implementation evaluation activities (surveys, focus groups, or interviews)

Number of staff from participating community-based harm reduction organizations who engaged in implementation evaluation activities, including technical assistance surveys, focus groups, and key informant interviews conducted during the implementation substudy. This outcome reflects participation in implementation evaluation activities conducted as a substudy within the PROVIDENT trial; results are reported as aggregated counts of participants engaged in each activity. Participants may have contributed to more than one implementation activity.

Participants completing implementation surveys
GroupValue95% CI
Implementation Substudy: Staff at Community-Based Organizations39
Participants participating in focus groups
GroupValue95% CI
Implementation Substudy: Staff at Community-Based Organizations12
Participants participating in key informant interviews
GroupValue95% CI
Implementation Substudy: Staff at Community-Based Organizations7

Sponsor's own description

The objectives of this project are to leverage surveillance data to predict future overdose outbreaks, and to evaluate the impact of a randomized, statewide, community-level intervention trial to target overdose prevention programs to neighborhoods at highest risk of future overdose deaths. This study develops and tests an opioid overdose forecasting tool, which will allow other states to identify and deploy interventions to communities at highest risk of opioid-related death. The findings from this study have the potential to significantly improve the allocation of resources to curb the opioid overdose epidemic in the United States.

Publications & conference data

5 peer-reviewed publications reference this trial (live from Europe PMC):

  1. Preventing Overdose Using Information and Data from the Environment (PROVIDENT): protocol for a randomized, population-based, community intervention trial.
    Marshall BDL, Alexander-Scott N, Yedinak JL, Hallowell BD, et al · · 2022 · cited 19× · PMID 34729851 · DOI 10.1111/add.15731
  2. PROVIDENT: Development and Validation of a Machine Learning Model to Predict Neighborhood-level Overdose Risk in Rhode Island.
    Allen B, Schell RC, Jent VA, Krieger M, et al · · 2024 · cited 10× · PMID 38180881 · DOI 10.1097/ede.0000000000001695
  3. An Overdose Forecasting Dashboard for Local Harm-Reduction Response.
    Krieger M, Yedinak J, Duong E, Macmadu A, et al · · 2025 · cited 4× · PMID 40325596 · DOI 10.1177/15248399251335620
  4. "Sometimes I'm interested in seeing a fuller story to tell with numbers" Implementing a forecasting dashboard for harm reduction and overdose prevention: a qualitative assessment.
    Gray JY, Krieger M, Skinner A, Parker S, et al · · 2025 · cited 4× · PMID 40055691 · DOI 10.1186/s12889-025-22004-y
  5. Assessing User Engagement With an Interactive Mapping Dashboard for Overdose Prevention Informed by Predictive Modeling in Rhode Island.
    Skinner A, Neill DB, Allen B, Krieger M, et al · · 2025 · cited 1× · PMID 40694437 · DOI 10.1097/phh.0000000000002200

Verify or expand the search:

Other recruiting trials for Opioid Overdose

Currently open trials in the same condition.

Other Brown University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05096429.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing